July 24, 2020
PAR-20-269 - Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
National Institute on Aging (NIA)
This Notice informs the extramural community of the early expiration of PAR-20-269 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional). It will be re-issued immediately as an RFA.
Jean Yuan, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: yuanx4@mail.nih.gov